Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Savoldo

Showing results (131-140 of 155) with videos related to

Pageof 16
Sort By:
The Journal of Clinical Investigation|June 9, 2016
Clinical responses with T lymphocytes targeting malignancy-associated κ light chainsCarlos A Ramos, Barbara Savoldo, Vicky Torrano, et al.
Blood|May 16, 2009
Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopesPatrick J Hanley, Conrad Russell Young Cruz, Barbara Savoldo, et al.
Blood|October 11, 2011
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastomaChrystal U Louis, Barbara Savoldo, Gianpietro Dotti, et al.
Cytotherapy|May 1, 2010
Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experienceConrad Russell Cruz, Patrick J Hanley, Hao Liu, et al.
Cancer Cell|December 1, 2023
ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cellsElisa Bergaggio, Wei-Tien Tai, Andrea Aroldi, et al.
Cytotherapy|February 1, 2014
Third-party umbilical cord blood-derived regulatory T cells prevent xenogenic graft-versus-host diseaseSimrit Parmar, Xiaoying Liu, Shawndeep S Tung, et al.
Nature Immunology|January 8, 2025
A multi-kinase inhibitor screen identifies inhibitors preserving stem-cell-like chimeric antigen receptor T cellsFeifei Song, Ourania Tsahouridis, Simone Stucchi, et al.
The Journal of Clinical Investigation|March 13, 2012
EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumorsRobert E White, Patrick C Rämer, Kikkeri N Naresh, et al.
Blood|May 16, 2015
Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantationXiaoou Zhou, Gianpietro Dotti, Robert A Krance, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2014
Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activityAlana A Kennedy-Nasser, Stephanie Ku, Paul Castillo-Caro, et al.
Pageof 16

Showing results (131-140 of 155) with videos related to

Sort By:
Pageof 16
The Journal of Clinical Investigation|June 9, 2016
Clinical responses with T lymphocytes targeting malignancy-associated κ light chainsCarlos A Ramos, Barbara Savoldo, Vicky Torrano, et al.
Blood|May 16, 2009
Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopesPatrick J Hanley, Conrad Russell Young Cruz, Barbara Savoldo, et al.
Blood|October 11, 2011
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastomaChrystal U Louis, Barbara Savoldo, Gianpietro Dotti, et al.
Cytotherapy|May 1, 2010
Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experienceConrad Russell Cruz, Patrick J Hanley, Hao Liu, et al.
Cancer Cell|December 1, 2023
ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cellsElisa Bergaggio, Wei-Tien Tai, Andrea Aroldi, et al.
Cytotherapy|February 1, 2014
Third-party umbilical cord blood-derived regulatory T cells prevent xenogenic graft-versus-host diseaseSimrit Parmar, Xiaoying Liu, Shawndeep S Tung, et al.
Nature Immunology|January 8, 2025
A multi-kinase inhibitor screen identifies inhibitors preserving stem-cell-like chimeric antigen receptor T cellsFeifei Song, Ourania Tsahouridis, Simone Stucchi, et al.
The Journal of Clinical Investigation|March 13, 2012
EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumorsRobert E White, Patrick C Rämer, Kikkeri N Naresh, et al.
Blood|May 16, 2015
Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantationXiaoou Zhou, Gianpietro Dotti, Robert A Krance, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2014
Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activityAlana A Kennedy-Nasser, Stephanie Ku, Paul Castillo-Caro, et al.
Pageof 16